PAX8 and serous adenocarcinoma: However, multiple lines of evidence from previous studies have rendered support to a tubal origin of these lesions (e.g., based on Pax8 or Ovgp1-based genetic targeting), in particular the serous adenocarcinoma [16,17,18,19].